Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
Frank Tacke, Ralf Weiskirchen
Annals of Translational Medicine (2021) Vol. 9, Iss. 8, pp. 729-729
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
Zui Tan, Hongbao Sun, Taixiong Xue, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 153
Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis
Beatrice Foglia, Erica Novo, Francesca Protopapa, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1764-1764
Open Access | Times Cited: 62
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Kailin Yang, Junpeng Chen, Tianqing Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH
Mathias B. Møllerhøj, Sanne Skovgård Veidal, Kirstine Tølbøl Thrane, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 5, pp. 1167-1186
Open Access | Times Cited: 46
Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD
Marta Martín-Fernández, Víctor Arroyo, Carmen Carnicero, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2217-2217
Open Access | Times Cited: 44
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
Stefano Ballestri, Alessandro Mantovani, Maria Di Girolamo, et al.
Metabolism and Target Organ Damage (2023) Vol. 3, Iss. 1, pp. 1-1
Open Access | Times Cited: 27
Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH
Raquel Fernández-Ginés, José Antonio Encinar, Maribel Escoll, et al.
Redox Biology (2024) Vol. 69, pp. 103027-103027
Open Access | Times Cited: 11
Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics
Salah Abdalrazak Alshehade
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 7, pp. 102377-102377
Closed Access | Times Cited: 11
Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis
Ting Dong, Guangan Hu, Zhongqi Fan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
Simona Cernea
Life (2024) Vol. 14, Iss. 2, pp. 272-272
Open Access | Times Cited: 8
Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance
Siyer Roohani, Frank Tacke
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7249-7249
Open Access | Times Cited: 44
PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes
Cristina C. Clement, Jaspreet Osan, Aitziber Buqué, et al.
Science Immunology (2022) Vol. 7, Iss. 74
Open Access | Times Cited: 37
Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes
Patrizia Carrieri, Abbas Mourad, Fabienne Marcellin, et al.
Liver International (2022) Vol. 42, Iss. 5, pp. 984-994
Open Access | Times Cited: 36
Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?
Teresa Auguet, Laia Bertran, Andrea Barrientos‐Riosalido, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13495-13495
Open Access | Times Cited: 28
Extracellular matrix remodelling in obesity and metabolic disorders
Vishal Musale, David H. Wasserman, Li Kang
Life Metabolism (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 16
Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
Yajie Fu, Yanzhi Zhou, Linhu Shen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: An overview and current perspectives
Mengyao Yan, Shuli Man, Long Ma, et al.
Metabolism (2022) Vol. 134, pp. 155264-155264
Closed Access | Times Cited: 24
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease
Gabriella Assante, Sriram Chandrasekaran, Stanley Ng, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Shuangshuang Zhao, Yan Guo, Xunzhe Yin
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 1, pp. 30-30
Open Access | Times Cited: 5
Eriodictyol downregulates UBA52 to promote autophagy and upregulates Nrf2/HO-1 to inhibit oxidative stress to ameliorate non-alcoholic fatty liver disease
Yongqing Cai, Lie Yuan, Kaiyang Wang, et al.
Journal of Functional Foods (2024) Vol. 113, pp. 106041-106041
Open Access | Times Cited: 5
Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels
Shuang Li, Shuangjiang Li, Linjing Guan, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Comprehensive Approach to Liver Cirrhosis Treatment: Integrating Ayurveda, Homeopathy, and Allopathy
Debabrata Dash, Palak Kesharwani, Raj Kumar Koiri
Pharmacological Research - Natural Products (2025), pp. 100184-100184
Closed Access
Human Mesenchymal Stromal Cells Resolve Lipid Load in High Fat Diet-Induced Non-Alcoholic Steatohepatitis in Mice by Mitochondria Donation
Sandra Nickel, Madlen Christ, Sandra Schmidt, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1829-1829
Open Access | Times Cited: 19
Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
Tieshan Teng, Shuai Qiu, Yiming Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7841-7841
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top